BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8217836)

  • 21. Role of granulocyte-macrophage colony-stimulating factor in Philadelphia (Ph1)-positive acute lymphoblastic leukemia: studies on two newly established Ph1-positive acute lymphoblastic leukemia cell lines (Z-119 and Z-181).
    Estrov Z; Talpaz M; Zipf TF; Kantarjian HM; Ku S; Ouspenskaia MV; Hirsch-Ginsberg C; Huh Y; Yee G; Kurzrock R
    J Cell Physiol; 1996 Mar; 166(3):618-30. PubMed ID: 8600166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production of granulocyte colony-stimulating factor and granulocyte/macrophage-colony-stimulating factor after interleukin-1 stimulation of marrow stromal cell cultures from normal or aplastic anemia donors.
    Migliaccio AR; Migliaccio G; Adamson JW; Torok-Storb B
    J Cell Physiol; 1992 Jul; 152(1):199-206. PubMed ID: 1377699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytogenetic features of multiple myeloma: impact of gender, age, disease phase, culture time, and cytokine stimulation.
    Nilsson T; Lenhoff S; Turesson I; Rylander L; Mitelman F; Westin J; Höglund M; Johansson B
    Eur J Haematol; 2002 Jun; 68(6):345-53. PubMed ID: 12225392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of cytokines on the toxicity of cytostatic drugs to normal bone marrow cells in vitro.
    Sundman-Engberg B; Paul C; Tidefelt U
    Cancer Chemother Pharmacol; 1998; 42(3):255-60. PubMed ID: 9685063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM; Gulati SC
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Granulocyte-colony stimulating factor, granulocyte-macrophage colony stimulating factor, PIXY-321, stem cell factor, interleukin-3, and interleukin-7: receptor binding and effects on clonogenic proliferation in acute lymphoblastic leukemia.
    Drach D; Estrov Z; Zhao S; Drach J; Cork A; Collins D; Kantarjian H; Andreeff M
    Leuk Lymphoma; 1994 Dec; 16(1-2):79-88. PubMed ID: 7535143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of granulocyte-macrophage colony-stimulating factor and interleukin 3 in human long-term bone marrow culture.
    Gibson FM; Bagnara M; Ioannidou E; Gordon-Smith EC
    Exp Hematol; 1992 Feb; 20(2):235-40. PubMed ID: 1544393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Importance of GM-CSF for in vitro cytogenetic bone marrow analysis in patients with myelodysplastic syndrome].
    Karásková J; Holena O; Michalová K
    Cas Lek Cesk; 1997 Oct; 136(20):633-7. PubMed ID: 9490208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-6 reduces the optimal growth in vitro of leukemic blast progenitors from acute myeloblastic leukemia patients.
    Suzuki T; Bessho M; Hirashma K; Tohda S; Nagata K; Imai Y; Nara N
    Acta Haematol; 1992; 87(1-2):63-8. PubMed ID: 1374992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro response of normal and aplastic anemia bone marrow to mast cell growth factor and in combination with granulocyte-macrophage colony-stimulating factor and interleukin-3.
    Gibson FM; Scopes J; Daly S; Ball SE; Gordon-Smith EC
    Exp Hematol; 1994 Mar; 22(3):302-12. PubMed ID: 8112428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Response of myelodysplastic syndrome marrow progenitor cells to stimualtion with cytokine combinations in a stroma-free long-term culture system.
    Soligo DA; Campiglio S; Servida F; Bossolasco P; Romitti L; Cortelezzi A; Lambertenghi Deliliers G
    Br J Haematol; 1996 Mar; 92(3):548-58. PubMed ID: 8616015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma.
    Zhang XG; Gaillard JP; Robillard N; Lu ZY; Gu ZJ; Jourdan M; Boiron JM; Bataille R; Klein B
    Blood; 1994 Jun; 83(12):3654-63. PubMed ID: 8204890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Demonstration of differential effects of cytokines on mast cells derived from murine bone marrow and peripheral blood mononuclear cells.
    Rottem M; Hull G; Metcalfe DD
    Exp Hematol; 1994 Nov; 22(12):1147-55. PubMed ID: 7523167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The Effect of Improved Culturing Method on the Detection Rate of Chromosome Karyotyping in Multiple Myeloma].
    Wang N; Fan KK; Yuan LJ; Jin HS; Wang LL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):1129-1133. PubMed ID: 35981372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of granulocyte-macrophage colony-stimulating factor (GM-CSF) receptors in a GM-CSF-dependent human myeloid leukemia cell line (AML-193) by interleukin-6.
    Li Y; Valeriote F; Chen B
    Exp Hematol; 1996 Feb; 24(2):94-100. PubMed ID: 8641372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multifactor stimulation of megakaryocytopoiesis: effects of interleukin 6.
    Quesenberry PJ; McGrath HE; Williams ME; Robinson BE; Deacon DH; Clark S; Urdal D; McNiece IK
    Exp Hematol; 1991 Jan; 19(1):35-41. PubMed ID: 1703492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in bone marrow cytogenetic characteristics between treated and untreated myeloma.
    Clark RE; Geddes AD; Whittaker JA; Jacobs A
    Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1789-93. PubMed ID: 2632260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Role of cytogenetics in the prognosis of patients with multiple myeloma].
    Paluszewska M; Dwilewicz-Trojaczek J; Stańczak H; Brycz-Witkowska J; Chmarzyńska-Mróz E; Rokicka M; Torosian T; Wasiutyński A; Jedrzejczak WW
    Pol Arch Med Wewn; 2003 Sep; 110(3):973-9. PubMed ID: 14699690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A modified cytogenetic study for multiple myeloma].
    Qin YW; Wei DL; Wang C; Yan SK; Gao YR; Cai Q
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Apr; 23(2):213-5. PubMed ID: 16604501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study of cytogenetic abnormalities in G-CSF stimulated peripheral blood cells and non-stimulated bone marrow cells of patients with myelofibrosis.
    Lozynskyy RY; Lozynska MR; Hontar YV; Huleyuk NL; Maslyak ZV; Novak VL
    Exp Oncol; 2016 Mar; 38(1):40-4. PubMed ID: 27031718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.